References
1. Martinez FD. Early-Life Origins of Chronic Obstructive Pulmonary
Disease. N Engl J Med 2016;375(9):871–878.
2. Bisgaard H, Jensen SM, Bønnelykke K. Interaction between asthma and
lung function growth in early life. Am J Respir Crit Care Med
2012;185(11):1183–1189.
3. Strunk RC, Weiss ST, Yates KP, Tonascia J, Zeiger RS, Szefler SJ,
CAMP Research Group. Mild to moderate asthma affects lung growth in
children and adolescents. J Allergy Clin Immunol 2006;118(5):1040–1047.
4. Covar RA, Spahn JD, Murphy JR, Szefler SJ, Childhood Asthma
Management Program Research Group. Progression of asthma measured by
lung function in the childhood asthma management program. Am J Respir
Crit Care Med 2004;170(3):234–241.
5. Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM,
Ost DE, Punjabi NM, Schatz M, Smyth AR, et al. Control of Confounding
and Reporting of Results in Causal Inference Studies. Guidance for
Authors from Editors of Respiratory, Sleep, and Critical Care Journals.
Ann Am Thorac Soc 2019;16(1):22–28.
6. O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW, START
Investigators Group. Severe exacerbations and decline in lung function
in asthma. Am J Respir Crit Care Med 2009;179(1):19–24.
7. Mahut B, Peyrard S, Delclaux C. Exhaled nitric oxide and clinical
phenotypes of childhood asthma. Respir Res 2011;12:65.
8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A,
Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al.
Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.
9. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH,
Enright PL, Hankinson JL, Ip MSM, Zheng J, et al. Multi-ethnic reference
values for spirometry for the 3-95-yr age range: the global lung
function 2012 equations. Eur Respir J 2012;40(6):1324–1343.
10. Quanjer PH, Weiner DJ. Interpretative consequences of adopting the
Global Lungs 2012 reference equations for spirometry for children and
adolescents. Pediatr Pulmonol 2014;49(2):118–125.
11. Denlinger LC, Phillips BR, Sorkness RL, Bleecker ER, Castro M,
DeBoer MD, Fitzpatrick AM, Hastie AT, Gaffin JM, Moore WC, et al.
Responsiveness to Parenteral Corticosteroids and Lung Function
Trajectory in Adults with Moderate to Severe Asthma. Am J Respir Crit
Care Med 2020 Dec 8.
12. Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C. Lung function
impairment evidenced by sequential specific airway resistance in
childhood persistent asthma: a longitudinal study. J Asthma
2010;47(6):655–659.
13. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM,
Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal,
population-based, cohort study of childhood asthma followed to
adulthood. N Engl J Med 2003;349(15):1414–1422.
14. McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML,
Wise RA, Szefler SJ, Sharma S, Kho AT, et al. Patterns of Growth and
Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med
2016;374(19):1842–1852.
15. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ,
Strunk RC, Zeiger RS, Murphy AJ, Weiss ST, Childhood Asthma Management
Program Research Group. Clinical predictors and outcomes of consistent
bronchodilator response in the childhood asthma management program. J
Allergy Clin Immunol 2008;122(5):921-928.e4.
16. Bui DS, Perret JL, Walters EH, Abramson MJ, Burgess JA, Bui MQ,
Bowatte G, Lowe AJ, Russell MA, Alif SM, et al. Lifetime Risk Factors
for Pre- and Post-Bronchodilator Lung Function Decline. A
Population-based Study. Ann Am Thorac Soc 2020;17(3):302–312.
17. Mogensen I, Vonk JM, Wijnant SRA, Zhou X, Boezen HM, Brusselle G,
Lahousse L, Janson C, Malinovschi A. Blood eosinophil level and lung
function trajectories: cross-sectional and longitudinal studies in
European cohorts. ERJ Open Res 2020;6(4).
18. van Rensen ELJ, Sont JK, Evertse CE, Willems LNA, Mauad T, Hiemstra
PS, Sterk PJ, AMPUL Study Group. Bronchial CD8 cell infiltrate and lung
function decline in asthma. Am J Respir Crit Care Med
2005;172(7):837–841.
19. Ulrik CS. Outcome of asthma: longitudinal changes in lung function.
Eur Respir J 1999;13(4):904–918.
20. Mahut B, Beydon N, Delclaux C. Overweight is not a comorbidity
factor during childhood asthma: the GrowthOb study. Eur Respir J
2012;39(5):1120–1126.
21. Graff S, Bricmont N, Moermans C, Henket M, Paulus V, Guissard F,
Louis R, Schleich F. Clinical and biological factors associated with
irreversible airway obstruction in adult asthma. Respir Med
2020;175:106202.
22. Tantisira KG, Fuhlbrigge AL, Tonascia J, Van Natta M, Zeiger RS,
Strunk RC, Szefler SJ, Weiss ST, Childhood Asthma Management Program
Research Group. Bronchodilation and bronchoconstriction: predictors of
future lung function in childhood asthma. J Allergy Clin Immunol
2006;117(6):1264–1271.
23. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock
IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS
guidelines on definition, evaluation and treatment of severe asthma. Eur
Respir J 2014;43(2):343–373.
24. Song WJ, Lee JH, Kang Y, Joung WJ, Chung KF. Future Risks in
Patients With Severe Asthma. Allergy Asthma Immunol Res
2019;11(6):763–778.
25. Bui DS, Lodge CJ, Burgess JA, Lowe A, Perret J, Bui MQ, Bowatte G,
Gurrin L, Johns DP, Thompson BR, et al. Childhood predictors of lung
function trajectories and future COPD risk: a prospective cohort study
from the first to the sixth decade of life. 544 2018 Jul 1 [accessed
2020 Oct 19]. http://spiral.imperial.ac.uk/handle/10044/1/57288
26. Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW,
Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American
Thoracic Society/European Respiratory Society statement: asthma control
and exacerbations: standardizing endpoints for clinical asthma trials
and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99.
Table 1. Characteristics of the 295 asthmatic children
according to the three groups of FEV1 % predicted
slope.